Krónikus gyulladásos demielinizációs polineuropátia (CIDP): vizsgálatok itt: Lengyelország
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in LengyelországA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Cracow, Lublin
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - 3. fázisTaking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Bydgoszcz, Cracow, Katowice, Lublin, Poznan, Rzeszow, Szczecin, Warsaw, Warszawa
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Cracow, Katowice, Lublin, Warsaw, Warszawa
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - 2. fázisTaking peopleImeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Bydgoszcz, Cracow, Katowice, Lublin, Poznan
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00 - 3. fázisTaking peopleA Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Where
- Bydgoszcz, Katowice, Krakow, Wroclaw
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07540221 - 2/3. fázisFut, nem toborozEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Lublin, Poznan
- Életkor
- 18 év and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bydgoszcz, Krakow, Lodz, Lublin, Warsaw, Wroclaw
- Életkor
- 18 év to 75 év
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - 3. fázisCsak meghívásosLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Lublin
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - 3. fázisTaking peopleA Phase III study to evaluate how the body processes Xembify in comparison to Gamunex-C and determine the safety and in people with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Bydgoszcz, Cracow, Katowice, Lublin, Piaseczno, Wroclaw, Wrocław
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to join2025-522165-30-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bydgoszcz, Cracow, Łódź, Lublin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 - 3. fázisTaking peopleA Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Cracow, Lublin, Warsaw
- Életkor
- 18 év and over
- People
- 59 worldwide
- Run by
- Takeda
See details and how to joinNCT06747351 · EU 2024-517450-95-00